Showing results (311-320 of 495) with videos related to
Sort By:
Pageof 50
Wiener Klinische Wochenschrift|September 3, 1982
[Platelet half-life in patients with primary hyperlipoproteinemia type IIa, IIb, and IV according to Fredrickson with and without clinical signs of atherosclerosis]E Jäger, H Sinzinger, K Widhalm, et al.Journal of Periodontal Research|February 1, 1996
Evidence that cyclosporine inhibits periodontal prostaglandin I2 synthesisA Nell, M Matejka, P Solar, et al.International Journal of Cardiology|November 1, 1989
Humoral regulation during cold-induced coronary arterial spasmT Stefenelli, H Sinzinger, H Sochor, et al.Wiener Klinische Wochenschrift|February 3, 1984
[111-Indium-labeled thrombocytes in the diagnosis of acute kidney transplant rejections and in monitoring the therapy of rejection reactions with prostacyclin]C Leithner, H Sinzinger, E Pohanka, et al.Aktuelle Gerontologie|September 1, 1980
[Age dependence of vascular prostacyclin formation in man (author's transl)]C Leithner, H Sinzinger, G Schernthaner, et al.Wiener Medizinische Wochenschrift (1946)|January 1, 1990
[Risk factors of atherosclerosis and awareness of risk in employees of a Viennese insurance company]K Weiss, S Egger, P Hirmann, et al.Agents and Actions. Supplements|January 1, 1992
Prostaglandin (PG) E1 and 13,14-dihydro (DH) PGE1 are diminishing radiation-induced arterial damageI Neumann, W Rogatti, I Virgolini, et al.Thrombosis Research|May 15, 1991
Interaction between prostaglandin E1 and nitric oxide (NO)R Katzenschlager, K Weiss, W Rogatti, et al.British Journal of Clinical Pharmacology|November 1, 1987
Development of optimal infusion regimens for epoprostenol using radio labelled platelet uptake over atherosclerotic lesions in manH Sinzinger, P Fitscha, J Kaliman, et al.Acta Medica Austriaca|January 1, 1985
[Therapy with interferon (recombinant IFN-alpha-2C) in myeloproliferative diseases with severe thrombocytoses]W Linkesch, H Gisslinger, H Ludwig, et al.Pageof 50